Join
Live feed
·
INSIDERFilingvia Quantisnow
NRX Pharmaceuticals Inc. logo

SEC Form 4: Hurvitz Chaim bought $20,125 worth of shares (70,000 units at $0.29), increasing direct ownership by 14% to 570,000 units

ByQuantisnow·Wall Street's wire, on your screen.
NRXP· NRX Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NRXP (NRX Pharmaceuticals Inc.) and more on Quantisnow.